Compounds > monobenzone
Page last updated: 2024-08-18

monobenzone and Malignant Melanoma

monobenzone has been researched along with Malignant Melanoma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonchak, JG; Chrobak, D; Eby, JM; Henning, SW; Johnson, SL; Krzywiec, A; Le Poole, IC; Willenborg, KA1
Bos, JD; Filippov, DV; Konijnenberg, D; Luiten, RM; Meeuwenoord, NJ; Melief, CJ; Picavet, DI; Tjin, EP; van den Boorn, JG; van der Veen, JP1
Bos, JD; Drijfhout, JW; Jong, EC; Konijnenberg, D; Luiten, RM; Melief, CJ; Picavet, DI; Reits, EA; van Capel, T; van den Boorn, JG; van Swieten, PF; van Veelen, PA; van Veen, HA1
Becker, JC; Schrama, D1
Luiten, RM; Melief, CJ; van den Boorn, JG1
Lerner, AB1

Reviews

2 review(s) available for monobenzone and Malignant Melanoma

ArticleYear
Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity.
    Pigment cell & melanoma research, 2011, Volume: 24, Issue:4

    Topics: Autoimmunity; Humans; Hydroquinones; Hypopigmentation; Melanoma; Models, Biological; Monophenol Monooxygenase; Vitiligo

2011
The Seiji memorial lecture. Pigment stories: from vitiligo to melanomas and points in between.
    Pigment cell research, 1992, Volume: Suppl 2

    Topics: Adult; Female; Humans; Hydroquinones; Male; Melanoma; Melanosis; Methoxsalen; Nevus, Pigmented; Paraneoplastic Syndromes; Prejudice; Skin Neoplasms; Skin Pigmentation; Social Values; Trioxsalen; Ultraviolet Rays; Vitiligo

1992

Other Studies

4 other study(ies) available for monobenzone and Malignant Melanoma

ArticleYear
Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin.
    Archives of biochemistry and biophysics, 2014, Dec-01, Volume: 563

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Topical; Animals; Cell Differentiation; Cell Survival; Cells, Cultured; Drug Synergism; Humans; Hydroquinones; Melanocytes; Melanoma; Mice; Mice, Inbred C57BL; Neoplastic Stem Cells; Skin Lightening Preparations; Skin Pigmentation; Tissue Culture Techniques; Tumor Cells, Cultured

2014
Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG.
    PloS one, 2010, May-13, Volume: 5, Issue:5

    Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; CD8-Positive T-Lymphocytes; Cell Proliferation; Dinucleoside Phosphates; Hydroquinones; Imiquimod; Immunoglobulin G; Immunotherapy; Injections, Subcutaneous; Killer Cells, Natural; Leukocyte Count; Lymphocyte Activation; Lymphocyte Depletion; Melanoma; Mice; Mice, Inbred C57BL; Pigmentation; Skin Neoplasms

2010
Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy.
    The Journal of investigative dermatology, 2011, Volume: 131, Issue:6

    Topics: Autoimmunity; Autophagy; Dendritic Cells; Haptens; HLA-DR Antigens; Humans; Hydroquinones; Lysosomes; Melanins; Melanocytes; Melanoma; Melanosomes; Monophenol Monooxygenase; Reactive Oxygen Species; Skin Pigmentation; T-Lymphocytes; Ubiquitination

2011
Breaking immunological tolerance to melanocyte differentiation antigens by hypopigmenting agents: a new means for melanoma immunotherapy?
    The Journal of investigative dermatology, 2011, Volume: 131, Issue:6

    Topics: Adaptive Immunity; Cell Differentiation; Humans; Hydroquinones; Immune Tolerance; Immunotherapy; Melanocytes; Melanoma; Skin Pigmentation

2011